The Globe and Mail reports in its Thursday edition that Apotex Health founder Barry Sherman left his four children a tidy fortune, estimated at $4-billion, when he and his wife Honey were murdered nearly nine years ago. The Globe's Andrew Willis writes that picking the right private equity firm, New York-based SK Capital Partners, to invest in their father's generic drug business in the wake of the family tragedy has dramatically boosted the heirs' already impressive wealth. Like the founders of big domestic names Lululemon, Dollarama and Canada Goose, the second generation of the Sherman clan can thank PE fund managers for turbocharging growth in their business. On Wednesday, Apotex stock soared in its debut on the Toronto Stock Exchange. The country's largest drug company raised $1.3-billion by selling shares at $24 each, the top end of the range set by investment bankers underwriting the largest Canadian initial public offering in five years. Apotex stock finished its first day of trading at $27, up $3 from the IPO price in an otherwise down market. The newly public company sports a $5.8-billion market capitalization. After the IPO, the Sherman family still has a 14-per-cent holding worth $805-million.